Clinical Trials Directory

Trials / Completed

CompletedNCT03744494

Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer

Comparison of the Therapeutic Efficacy and Patient Satisfaction of Three Techniques of Bilateral Orchidectomy in Prostate Cancer Patients of a Nigerian Sub-population (TEPSO)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
University College Hospital, Ibadan · Academic / Other
Sex
Male
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The therapeutic efficacy of three types of orchidectomy was ascertained as well as the QoL and scrotal cosmetic satisfaction of patients in the three surgical arms. Two of these surgeries produced a pseudotesticle (BSCO, BESO) while one (BSO) did not.

Detailed description

Patients with prostate cancer (PCa) were grouped into three surgical arms: BSO (bilateral simple orchidectomy), BSCO (bilateral subcapsular orchidectomy) and BESO (bilateral epididymal-sparing orchidectomy). Preoperatively, baseline serum testosterone, PSA, Quality of life (QoL) and pre-operative testicular volumes were obtained. Timed interval sampling for serum testosterone and PSA variation was done post-operatively. By three months post-op, the cosmetic appeal of the scrotal appearance, post-operative pseudotesticular volumes and QoL were also assessed. The therapeutic efficacy of the surgeries was determined by the rates of decline of serum testosterone and PSA, as well as the nadirs achieved. The variations in the pre-and post-operative QoL was analysed.

Conditions

Interventions

TypeNameDescription
PROCEDUREBilateral simple orchidectomy (BSO)
PROCEDUREBilateral Subcapsular Orchidectomy
PROCEDUREBilateral Epididymal-sparing Orchidectomy

Timeline

Start date
2016-03-02
Primary completion
2018-02-26
Completion
2018-02-26
First posted
2018-11-16
Last updated
2023-05-09

Locations

1 site across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT03744494. Inclusion in this directory is not an endorsement.